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Aim. To collect data on the use of placebo interventions by GPs in Germany.
Methods. A questionnaire was mailed to 400 randomly selected GPs in Bavaria. Non-responders
were reminded by telephone after 4 weeks and were given a second copy of the questionnaire
after a further 3 weeks.
Results. In all, 208 completed questionnaires were returned. The majority of GPs (88%) have
used a placebo at least once in their practice; 45% have used pure placebos, such as saline injec-
tions and sugar pills, at least once last year; the median frequency of use was 5 [interquartile
range (IQR), 2–10]. The use of impure placebos during the past year was more common: 76%
of GPs have used impure placebos, i.e. medical interventions that have pharmacological or
physical activity but have no intrinsic effect (e.g. pharmacological or physical action) on the pa-
tient’s disease or its symptoms, with a median frequency of 20 times per year (IQR, 10–50). The
main reason for the use of placebo was a possible psychological effect, followed by the expec-
tation of patients to receive a treatment. For the majority of GPs placebo interventions were eth-
ically justified if they were used for a possible psychological effect.
Conclusions. Placebo interventions are a widely accepted part of medical treatment in German
general practices and are used primarily for their psychological effects. Impure placebos are
used much more frequently than pure placebos.
Keywords. Medical ethics, placebo effect, placebos/therapeutic use, primary health care,
professional–patient relations, questionnaires.
Introduction
In the past decade, numerous studies have shown that
placebo interventions can improve the health and
well-being of patients. The deliberate use of placebos
in practice, however, remains problematic for ethical
reasons. At the same time, surveys in various countries
have shown that physicians use placebos regularly in
their practice.1 For example, a recent survey of intern-
ists and rheumatologists in the United States showed
that 80% of them prescribe placebo treatments to
their patients, 46% at least once a month.2
The frequency of placebo administration differs be-
tween hospital and outpatient setting: According to
a Danish study 86% of GPs confirmed the use of pla-
cebo interventions in the past year in contrast to only
54% of physicians in hospital.3 Furthermore, the fre-
quency of use of placebo seems to vary with the type
of placebo: A Swiss survey showed that impure place-
bos are used more often than pure placebos.4 Impure
placebos are defined as medical interventions that
have a pharmacological or physical activity, but not
for the actual disease or its symptoms (e.g. antibiotics
for viral infections, vitamin supplements without vita-
min deficiency), while pure placebos are inert treat-
ments, such as sugar tablets and saline injections.
The present study aimed to investigate the frequencies
and motivations for the use of pure and impure placebos
in German practices of general medicine. We were also
interested in the attitudes towards placebo use, and what
GPs tell their patients if they want to administer a pla-
cebo. Since the use of placebos probably depends on what
the person knows about placebo effects, we also posed
questions about the assumed mechanisms of placebo an-
algesia and the potential impact of positive expectations
on health.
Methods
Questionnaire and procedure
A pilot version of the questionnaire was sent to 20 GPs
in Bavaria. A further five GPs were interviewed after
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filling out the pilot version in order to assure the clarity
of questions. The final questionnaire consisted of seven
questions focusing on pure placebos, eight questions
on impure placebos and seven questions on demo-
graphic data (Appendix). Questions about impure
placebos were posed without using the term ‘placebo’.
Instead, they were described as drugs and other thera-
pies with no intrinsic effects (e.g. pharmacological or
physical activity) on the current patient’s symptoms.
The questionnaire was sent to 400 GPs. This was
a random selection from the 6700 GPs in the database
of the Bavarian Medical Association. Data collection
was conducted from November 2009 to February
2010. A package containing a letter explaining the
purpose of the study, a numbered questionnaire,
a stamped return envelope and a small gift was sent
to each doctor. The letter promised a lottery drawing
of V100 among the responders. After identifying the
non-responders, the questionnaires were renumbered
to ensure anonymity. Non-responders were reminded
by telephone to complete the questionnaire after
4 weeks and were given a second questionnaire copy
after a further 3 weeks.
Data analysis
We used descriptive statistics to summarize the results.
Subgroup comparisons were done with Chi-square test.
Statistical analysis was performed with SPSS (version
18). A P-value < 0.05 was considered significant.
Results
Study population
In all, 219 of 400 questionnaires (55%) were returned.
Eleven physicians, who worked exclusively as a psy-
chotherapist, were excluded. Thus, we analysed 208 of
389 questionnaires, representing a response rate of
53%. Demographic characteristics of responders are
summarized in TABLE 1.
Frequencies of placebo use
Eighty-eight per cent of GPs confirmed that they have
used pure and/or impure placebos at least once in
their practice. Of the 208 physicians, 101 (49%)
reported that they have used pure placebos outside of
clinical trials, and 94 (45%) have done so at least once
during the last year. The median frequency of use per
year was 5 [interquartile range (IQR), 2–10]. Forty-
one GPs (21%) had placebo tablets in their practice
in stock. The use of drugs and other therapies with no
intrinsic activity (e.g. pharmacological or physical ac-
tivity) for the patient’s current symptoms (so-called
‘impure placebos’) was confirmed by 175 of the 208
physicians (84%). One hundred and fifty-seven GPs
(76%) reported that they have used impure placebos
at least once during the last year, with a median fre-
quency of 20 times per year (IQR, 10–50). Most often,
herbal remedies were used as impure placebos (73%),
followed by homeopathic remedies (62%), vitamin
preparations (62%), minerals and micronutrients
(58%), mild sedatives (30%), massages (30%), acu-
puncture (21%) and antibiotics (20%).
Using a case example, we asked the doctors how they
would treat a patient with cold and cough, when the
patient insisted on antibiotics, but there was no evidence
of a bacterial aetiology of his symptoms. In such a situa-
tion, 25% of surveyed GPs would prescribe antibiotics.
Reasons for the use of placebo
In all, 78 of the 101 (77%) doctors, who gave pure place-
bos, used them because of their psychological effect, fol-
lowed by the expectation of the patient to receive
a treatment (57%), the impression of GPs that the patient
wanted more drugs than necessary (47%), the handling of
a difficult treatment situation (46%) and non-specific
complaints (31%). A quarter of GPs (25%) reported
the use of pure placebos for diagnostic reasons. Other
reasons were the prevention of drug dependence (22%),
and use as an additional treatment option (19%).
The most common reason for the use of impure place-
bos was a possible psychological effect (79%), followed
by the expectation of the patient to receive a treatment
(52%), the use as an additional treatment option (47%),
the handling of a difficult treatment situation (47%) and
non-specific complaints (42%).
We conducted exploratory analysis in order to learn
more about the possible motives of the 25% of GPs, who
would prescribe antibiotics for non-bacterial infections, if
the patient insists. Among all users of impure placebos,
this subgroup used impure placebos more frequently
because the patient expected a treatment (68% versus
46%; P = 0.011), in order to deal with a difficult treatment
situation (62% versus 41%; P = 0.026), or as a further
treatment option (62% versus 41%; P = 0.026).
Patient information
The ways in which GPs inform their patients during
the administration of pure and impure placebos is
summarized in Table 2. Only a few doctors informed
their patients that the treatment itself had no intrinsic
effect on the current health complaints.
TABLE 1 Demographic characteristics of respondents
Variable n
- Age, mean ± SD 204 52.8 ± 7.6
- Males/females, n (%) 208 139 (67%)/69 (33%)
- Certified specialization
for general practice or
internal medicine, n (%)
208 181 (87%)
- Years in practice,
mean (SD)
208 17.1 (9%)
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Attitudes
The attitudes towards the placebos were different for
users and non-users of both pure placebos (Table 3)
and impure placebos (Table 4). The most frequent jus-
tification for the use of placebo was a possible psycho-
logical effect.
Placebo-related beliefs
The first question with respect to pure placebos pre-
sented the case of a chronic pain patient who received
a saline injection instead of his usual analgesics and re-
ported pain relief thereafter. The GPs were asked
about their beliefs regarding the reasons for this im-
provement. The answers are displayed in Figure 1.
When asked about possible effects of expectations,
197 doctors (95%) answered that subjective symptoms
such as stress could be relieved; 184 doctors (89%)
deemed possible that disease-related subjective symp-
toms, as pain or itching, would improve; 159 GPs
(76%) expected that bodily functions, such as auto-
nomic and immunological processes, would improve.
Only three doctors (1%) did not expect any improve-
ments by expectations.
Discussion
This is the first survey on the use of placebo interven-
tions in outpatients in Germany. In all, 88% of re-
spondents had administered either a pure or an
impure placebo at least once in their practice. Impure
placebos were used much more frequently than pure
placebos: They were administered by more physicians
(76% versus 45% in the preceding year) and more of-
ten (median 20 versus 5 times in the preceding year).
For both pure and impure placebos, the most fre-
quently reported reason for use was a possible psycho-
logical effect. The majority of GPs believed that
expectations can improve subjective and objective
symptoms. Both pure and impure placebos were usu-
ally administered without informing the patient that
the treatment had no intrinsic effect on the current
health complaints.
The response rate of 55% in our survey is acceptable
but not high. Our sample consisted only of GPs from
Bavaria, and we cannot rule out that the results may
be different in other states of Germany. A major prob-
lem in any survey on placebo use is the concept of
impure placebo. The decision whether an intervention
is still an active treatment or a placebo depends on
personal attitudes and situational factors. If physicians
are asked to define placebo they generally describe
TABLE 2 Information of patients by GPs when giving out pure pla-
cebos (n = 101) and impure placebos (n = 175)
Information Pure
placebos, n (%)
Impure
placebos, n (%)
- Treatment stimulates
self-healing powers
49 (49%) 136 (78%)
- Treatment is
highly effective
46 (46%) 49 (28%)
- Treatment has
helped other patients
44 (44%) 65 (37%)
- Description of
expected effects
12 (12%) 57 (33%)
- No information 11 (11%) 8 (5%)
- Treatment itself
actually is not effective
2 (2%) 10 (6%)
TABLE 3 Attitudes towards the use of pure placebos by users (n = 101)
and non-users (n = 107)
Item User,
n (%)
Non-user,
n (%)
Chi-quadrat
P-value
Acceptable, . . .
- when used for their
psychological effect
94 (93.1) 67 (62.6) <0.001
- when used for
diagnostic reasons
62 (61.4) 36 (33.6) <0.001
- because they do
not harm
50 (49.5) 40 (37.4) 0.052
- when all other
treatment options
are exhausted
36 (35.6) 34 (31.8) 0.329
Not acceptable, because of . . .
- threatening the
doctor–patient
relationship
2 (2.0) 30 (28.0) <0.001
- decepting the patient 3 (3.0) 25 (23.4) <0.001
- lack of efficacy 0 (0.0) 5 (4.7) 0.034
- legal problems 1 (1.0) 5 (4.7) 0.213
TABLE 4 Attitudes towards the use of impure placebos by users (n =
175) and non-users (n = 33)
Item User,
n (%)
Non-user,
n (%)
Chi-quadrat
P-value
Acceptable, . . .
- when used for their
psychological effect
144 (82.3) 14 (42.4) <0.001
- when clinical
experience
showed
usefulness
113 (64.6) 18 (54.5) 0.327
- when all other
treatment
options are
exhausted
110 (62.9) 9 (27.3) <0.001
- when patient’s
demand
95 (54.3) 6 (18.2) <0.001
Not acceptable, because of . . .
- decepting the
patient
2 (1.1) 9 (27.3) <0.001
- threatening the
doctor–patient
relationship
6 (3.4) 8 (24.2) <0.001
- lack of efficacy 1 (0.6) 3 (9.1) 0.013
- legal problems 6 (3.4) 1 (3.0) 1.000
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pure placebos (5). Many physicians do not know the
term impure placebo, and surveys either explain it in
questionnaires or—as we did—use circumscriptions.
The data on pure placebos are therefore more reliable
than the data on impure placebos.
The frequency of placebo use in our study is compa-
rable to data from Denmark and the United States, ac-
cording to which 86% and 80% of GPs or internists
give placebos.2,3 Furthermore, the proportion of Ger-
man physicians who use pure placebos in outpatients is
similar to that in the hospital6 and to respective data
from Israel.7 These data are contrasted by recent results
from Switzerland, where only 17% of GPs confirmed
the use of pure placebos.4 Similarly, the use of impure
placebos in the Swiss survey was lower than in ours
(54% versus 84%, respectively). Whether these differ-
ences will be attributable to national differences or to
different types of questions remains to be investigated.
Impure placebos seem to be used rather regularly by
German GPs at a first glance (in median, 20 times per
year). Although the true figure may even be higher, we
want to emphasize that German GPs treat 250 pa-
tients per week.8 Thus, impure placebos appear to be
prescribed more sporadically than regularly.
Our findings suggest that most GPs—possibly because
of their own experiences—take placebo effects seriously.
However, there were also more pragmatic reasons for
the administration of placebos, such as the request
for treatment of the patient, a difficult treatment situa-
tion, or non-specific complaints of the patients. Appar-
ently, GPs feel sometimes under pressure to administer
a treatment although there is no specific treatment for
the current patients’ symptoms. Then they resort to
placebo interventions in order to meet the patients’
needs.9 Especially the deeper motivations of prescribing
impure placebos could be even more complex. Qualita-
tive studies suggest that a complex mixture of internal-
ized role models, perceived patient expectations, fear of
conflicts and lack of time play a major role.9,10 Also the
question of what exactly determines the choice of a pure
or impure placebo remains unclear. These questions
probably require qualitative approaches to be resolved.
Only a minority of physicians informed their pa-
tients that the treatment had no physical or pharmaco-
logical effect on the current condition. The most
popular information during administration of placebos
was the stimulation of self-healing powers (Table 2).
This seems plausible since it is a popular concept to
describe the effects of alternative treatments and pla-
cebo interventions.11,12
The GPs’ ideas about the mechanisms of placebo
analgesia (Fig. 1) fit well with the latest understanding
of the psychological mechanisms of placebo effects.13
Few doctors have argued that the pain was psycho-
genic, simulated or not real, or the patient was men-
tally unstable. This is in contrast to a survey of thirty
years ago, when the majority of doctors still used pla-
cebos to determine whether pain was real.14
The attitude of GPs with respect to the administra-
tion of placebo interventions was surprisingly liberal.
Both pure and impure placebos were regarded ethically
justifiable for most of the GPs if used for a possible psy-
chological treatment effect. Ethical concerns regarding
the impairment of the doctor–patient relationship and
deceptive behaviour were almost exclusively found
among non-users (Tables 3 and 4). A disturbing finding
FIGURE 1 GPs’ beliefs regarding the reasons for pain relief by placebo
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was that some of the GPs do not hesitate to give impure
placebos, which are potentially harmful, such as antibi-
otics for common cold with no evidence for a bacterial
genesis. Non-indicated prescription of antibiotics may
be detrimental and clearly is in contrast with the ethical
principle of ‘nil nocere’. Also the use of ‘harmless’ pla-
cebos is ethically controversial.15 The German Medical
Association has recently defined a few situations in
which placebos can be administered in an ethically ac-
ceptable way.16 Following these recommendations, the
physician can use placebos without mentioning the
term placebo. In contrast, in the USA, the non-decep-
tive and transparent use of placebos is discussed as the
only viable way to administer placebos.17
In conclusion, we found evidence for a widespread
and liberal use of placebo interventions among Ger-
man GPs. The proportion of GPs who confirmed the
use of placebos was pretty similar to most available
data from other countries. Placebo effects were per-
ceived as real and serious phenomena. Qualitative
studies are needed to better understand the GPs’ mo-
tivations, especially for the use of impure placebos.
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Appendix: English translation of the
questionnaire
Questionnaire on the use of non-specific treatment
effects in ambulatory health care
I. Questionnaire
1. A forty-year-old man, self-employed, visits you in
your practice complaining of a cold and cough. He
wants an antibiotic, so that he can work again as
soon as possible. On examination, you can see no
medical indication for an antibiotic. The patient in-
sists, however, as antibiotics had helped him very
well during the last cold. What would you do most
likely in that situation? (multiple answers possible)
h Prescribe an antibiotic.
h Prescribe/recommend a drug or a treatment for
symptoms of common cold.
h Offer a check-up in the next few days.
h Other:_____________________________________
2. Have you ever used medicine or therapies, even if
you considered that they had no intrinsic effect
(e.g. pharmacological or physical action) on the pa-
tient’s disease or its symptoms?
h Yes
h No continue with question 7
3. Rough estimate, in how many patients in the last
year?
In approx. ______ patients in the last year.
4. What was your motivation? (multiple answers
possible)
Page 5 of 7Placebo use in Germany
 at UB der LM
U M
uenchen on August 2, 2011
fam
pra.oxfordjournals.org
D
ow
nloaded from
 
h Because the patient was expecting a therapy.
h Because of a possible psychological treatment
effect.
h In patients with symptoms that could not be
ascribed to any particular disease (‘non-specific
complaints’).
h To be able to still offer a treatment option to
patients with untreatable, incurable disease.
h For constantly complaining patients, to bridge
a difficult treatment situation.
h For other reasons: _________________________
5. Which forms of drugs/therapies have you already
used for that purpose (see question 2)? (multiple
answers possible)
(Here are just meant situations where you person-
ally felt that the treatment has no intrinsic/specific
effects on the actual symptoms; we do not mean
the general use of these treatments).
h Minerals and trace elements
h Vitamins
h Mild sedatives
h Antibiotics
h Homeopathic remedies
h Phytotherapeutics
h Acupuncture
h Massages
h Other: ___________________________________
6. How did you inform your patients? (multiple
answers possible)
h This is a highly effective drug/a highly effective
therapy.
h This therapy has helped many other patients.
h This treatment promotes self-healing/the
healing process.
h This is a treatment without pharmacological or
physical effect for your condition.
h I said what effect is expected from the therapy.
h I said nothing.
h I said (please add yourself): _________________
7. What is your opinion towards the use of drugs and
other therapies that do not have any intrinsic effect
(e.g. pharmacological or physical action) on the cur-
rent disease of the patient or its symptoms? (multi-
ple answers possible)
h Are acceptable if they are used for their
psychological effect.
h Are acceptable when all other therapies have
been exhausted.
h Are acceptable when the patient wants this
therapy.
h Are acceptable if the clinical experience has
shown a benefit.
h Are not acceptable because they involve the
deception of the patient.
h Are not acceptable because they endanger the
trust between doctor and patient.
h Are not acceptable because the efficacy is
insufficient.
h Are not acceptable because of legal problems.
8. Maybe you know the following case: A hospital pa-
tient with severe pain receives a painkiller iv 3
times a day and on demand. On days with very high
needs the painkiller is occasionally replaced by sa-
line injections. Upon request, the patient reported
in each case that the ‘painkiller’ worked well. What
conclusions can you draw from the effectiveness of
the saline injection? (Multiple answers possible)
h The pain had not organic cause, but was
psychogenic.
h The pain was not particularly strong.
h The pain was imagined.
h The patient is very suggestible.
h The patient is mentally unstable.
h The patient has simulated the pain.
h The intensity of pain decreased naturally.
h The patient has given a favour answer.
h The pain reduction was conditioned (learned).
h The expectation of pain reduction has led to the
decrease in pain.
h The positive attention by the nursing staff has
led to a decrease in pain.
h Other:____________________________________
9. Do you have pre-fabricated placebo preparations
(e.g. placebo tablets, injections with saline solution,
artificial sweetener pills, etc.) in stock in your
practice?
h Yes
h No
10. Did you ever use in your practice placebos (e.g.
placebo pills, saline injections, sweeteners, etc.)
outside of clinical trials?
h No continue with question 14
h Yes
11. Rough estimate, in how many patients in the last
year?
In approx. _____ patients in the last year
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12. What was your motivation? (multiple answers pos-
sible)
h Because the patient was expecting a therapy.
h Because of a possible psychological treatment
effect.
h In patients with symptoms that could not be
ascribed to any particular disease (‘non-specific
complaints’).
h To be able to still offer a treatment option to
patients with untreatable, incurable disease.
h For constantly complaining patients, to bridge
a difficult treatment situation.
h If a patient asked for more drugs than you
thought necessary.
h As a test of whether symptoms were psychogenic
or organic (differential diagnosis).
h To prevent drug dependence.
h For other reasons: _________________________
13. What did you tell your patient? (multiple answers
possible)
h This is a highly effective drug or a highly effective
therapy.
h This treatment has helped many other patients.
h This treatment promotes self-healing/the healing
process.
h This is a treatment without pharmacological or
physical effect.
h I said what effect is expected from the therapy.
h I said nothing.
h I said: (Please add yourself) _________________
14. What is your attitude towards the use of placebos?
(multiple answers possible)
h Are acceptable if they are used for their
psychological effect.
h Are acceptable when all other therapies have
been exhausted.
h Are acceptable if they are used as a diagnostic.
h Are acceptable because they do not harm.
h Are not acceptable because they involve the
deception of the patient.
h Are not acceptable because they endanger the
trust between doctor and patient.
h Are not acceptable because the efficacy is
insufficient.
h Are not acceptable because of legal problems.
15. The placebo effect is often defined the propor-
tion of improvement, which goes back to
a positive expectation of the patient and not to
the specific effect factors of treatment (e.g. their
pharmacological ingredients). What kinds of
improvements can have positive expectations
of the patient you think? (multiple answers
possible)
h Positive influence on general subjective symptoms,
e.g. stress reduction, relaxation.
h Positive influence on disease-relevant
subjective symptoms, e.g. decrease of pain,
itch, tinnitus.
h Positive influence on bodily functions, e.g.
improvement of vegetative, biochemical or
immunological functions.
h Positive expectations do not produce any
improvement.
II. Background information
1. Your age: ________
2. Your sex:
h female
h male
3. Are you a specialist?
h No
h yes, namely for ___________________________
4. How many years have you been in your practice?
For approx. _____ years
5. In which area the practice is specialized?
_____________________________________________
6. How many patients do you treat on average per
week? approx. _____ patients per week
7. Would you be prepared for a personal interview on
the subject?
h Yes
h Possibly
h No
Thank for your help!
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